Abstract
In this review we describe in detail the available technologies used for investigating the substrate specificity of proteases. Critical comparison of the available detection methods and their choice for certain type of screening is discussed. We present successful strategies along with appropriate examples for the design and synthesis of combinatorial libraries of substrates using both chemical and biological approaches. Proteomic tools for the identification of natural substrates of proteases are also discussed.
Keywords: Protease, substrate, library, fluorogenic, substrate specificity, combinatorial, positional scanning substrate combinatorial library, MEROPS, Activity Based Probes, ABPs, AMC, 7-amino-4-methylcoumarin, AFC, 7-amino-4-trifluoromethylcoumarin, ACC, 7-amino-4-carbamoylmethylcoumarin, 6-amino-1-naphtalenesulfonamide, ANSN, substrate activity screening, SAS, N-acyl-7-amino-4-methylcoumarin acetic acid, AMCA, p-nitroanilide, pNA, 5-fluorosalicylic acid, fsa, Tb(EDTA), rhodesain, Trypanasoma brucei, quencher, Leishmania mexicana, stromelysin, matrilysin, collagenase-3, MMP-2, MT1-MMP, furin, thrombin, granzyme B, PROTOMAP, iTRAQ, iCat, PICS, Proteomic Identification of protease Cleavage Sites, serine proteases, aspartic proteases, cysteine proteases
Current Medicinal Chemistry
Title: Current Strategies for Probing Substrate Specificity of Proteases
Volume: 17 Issue: 33
Author(s): M. Poreba and M. Drag
Affiliation:
Keywords: Protease, substrate, library, fluorogenic, substrate specificity, combinatorial, positional scanning substrate combinatorial library, MEROPS, Activity Based Probes, ABPs, AMC, 7-amino-4-methylcoumarin, AFC, 7-amino-4-trifluoromethylcoumarin, ACC, 7-amino-4-carbamoylmethylcoumarin, 6-amino-1-naphtalenesulfonamide, ANSN, substrate activity screening, SAS, N-acyl-7-amino-4-methylcoumarin acetic acid, AMCA, p-nitroanilide, pNA, 5-fluorosalicylic acid, fsa, Tb(EDTA), rhodesain, Trypanasoma brucei, quencher, Leishmania mexicana, stromelysin, matrilysin, collagenase-3, MMP-2, MT1-MMP, furin, thrombin, granzyme B, PROTOMAP, iTRAQ, iCat, PICS, Proteomic Identification of protease Cleavage Sites, serine proteases, aspartic proteases, cysteine proteases
Abstract: In this review we describe in detail the available technologies used for investigating the substrate specificity of proteases. Critical comparison of the available detection methods and their choice for certain type of screening is discussed. We present successful strategies along with appropriate examples for the design and synthesis of combinatorial libraries of substrates using both chemical and biological approaches. Proteomic tools for the identification of natural substrates of proteases are also discussed.
Export Options
About this article
Cite this article as:
Poreba M. and Drag M., Current Strategies for Probing Substrate Specificity of Proteases, Current Medicinal Chemistry 2010; 17 (33) . https://dx.doi.org/10.2174/092986710793205381
DOI https://dx.doi.org/10.2174/092986710793205381 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
DNA-Binding Properties of Poly(ADP-Ribose) Polymerase: A Target for Anti-Cancer Therapy
Current Drug Targets Novel Marine-Derived Anti-Cancer Agents
Current Pharmaceutical Design Engineered Biosynthesis of Medicinally Important Plant Natural Products in Microorganisms
Current Topics in Medicinal Chemistry Advances in Nanocarriers for Anticancer Drugs Delivery
Current Medicinal Chemistry Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer
Current Pharmaceutical Design Addressing the Challenge: Current and Future Directions in Ovarian Cancer Therapy
Current Gene Therapy Role of PARP Inhibitors in Cancer Biology and Therapy
Current Medicinal Chemistry RNA Sensors as a Mechanism of Innate Immune Evasion among SARSCoV2, HIV and Nipah Viruses
Current Protein & Peptide Science Bis(thiosemicarbazone) Metal Complexes as Therapeutics for Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Application of Nanotechnology in the Treatment and Diagnosis of Gastrointestinal Cancers: Review of Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Approaches Targeting KV10.1 Open a Novel Window for Cancer Diagnosis and Therapy
Current Medicinal Chemistry MicroRNAs-Based Therapeutic Strategy for Virally Induced Diseases
Current Drug Discovery Technologies Imaging Adoptive Cell Transfer Based Cancer Immunotherapy
Current Pharmaceutical Biotechnology Hypericin Lights Up the Way for the Potential Treatment of Nasopharyngeal Cancer by Photodynamic Therapy
Current Clinical Pharmacology Target Genetic Abnormalities for the Treatment of Colon Cancer and Its Progression to Metastasis
Current Drug Targets Hypersensitivity to Antineoplastic Agents
Current Pharmaceutical Design An Update on JAK Inhibitors
Current Medicinal Chemistry Lung Cancer Chemotherapy, New Treatment and Related Patents
Recent Patents on Anti-Cancer Drug Discovery Could Growth Factor-Mediated Extracellular Matrix Deposition and Degradation Offer the Ground for Directed Pharmacological Targeting in Fibrosarcoma?
Current Medicinal Chemistry Impact of the Somatotrope Growth Hormone (GH)/Insulin-Like Growth Factor 1 (IGF-1) Axis Upon Thymus Function: Pharmacological Implications in Regeneration of Immune Functions
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)